Werkgroep Cardiologische centra Nederland

DIAMOND (Recruiting)

A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel Group Study of Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of HF.
Medicine
Patiromer
Population
Heart failure
Phase
IIIb
Starting year
2019
More information
Clinicaltrials.gov

Director of Study

drs. F.J. Prins (Cardioloog)
Helmond, Elkerliek Ziekenhuis